Home About Login Current Archives Announcements Editorial Board
Submit Now For Authors Call for Submissions Statistics Contact
Home > Archives > Volume 20, No 11 (2022) > Article

DOI: 10.14704/nq.2022.20.11.NQ66084

Calculation the Prevalence rate of lung cancer for the period from 2012 to 2021 / Iraq /Karbala

Furqan Abbas Tawil, Shaymaa Awad Kadhim, and Abdalsattar Kareem Hashim

Abstract

The second leading cause of death worldwide, behind cardiovascular disease, is cancer. In the body, cancer can develop everywhere. Men and women alike are significantly affected by lung cancer. The prevalence and mortality rate of cancer patients have increased in Iraq as well. The current study is an epidemiological and statistical investigation. Al-Hussein Medical City provided information on lung cancer patients in the Karbala Governorate between the years of 2012 and 2021. Age, gender, and geographic region were used to separate the data. Additionally, the prevalence rate for each district within the governorate was established. Compared to the other age categories, there were more patients in the group of those 45 and older. According to the study's findings, the numbers climbed overall, with the exception of 2013 and 2015, which were likewise high when compared to before and after the governorate of Karbala. A number of governorates that frequently visited the medical facility were also included. At a rate of 44.04 cases per 100,000 persons, there were 383 men and 201 women who had lung cancer. There was an increase in the number of patients. The Holy Karbala Center served 298 patients (190 males and 108 women), however there were remarkably few good deeds noted there. among the clients (7 injuries for mans and 3 injuries for women). Calculations of prevalence and rate of change revealed a rise in the rate. Specifically, the chi-square test for statistical significance, where the p-value was not statistically significant, was used to analyze the importance of this statistic using SPSS version 20.

Keywords

Karbala Governorate, lung Cancer, SPSS Program, Prevalence Rate, Percentage Change.

Full Text

PDF

References

?>